These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
434 related items for PubMed ID: 30465175
1. Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease. Yamashita H, Okada A, Naora K, Hongoh M, Kinoshita Y. Dig Dis Sci; 2019 Mar; 64(3):823-831. PubMed ID: 30465175 [Abstract] [Full Text] [Related]
3. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they? de Bortoli N, Martinucci I, Savarino E, Bellini M, Bredenoord AJ, Franchi R, Bertani L, Furnari M, Savarino V, Blandizzi C, Marchi S. Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024 [Abstract] [Full Text] [Related]
4. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux. Akiyama J, Hosaka H, Kuribayashi S, Moriyasu S, Hisada Y, Okubo H, Watanabe K, Imbe K, Nagata N, Kojima Y, Yokoi C, Uemura N, Shimoyama Y, Kawamura O, Yamada M, Kusano M. Digestion; 2020 Jan; 101(2):174-183. PubMed ID: 30897577 [Abstract] [Full Text] [Related]
5. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy. Galindo G, Vassalle J, Marcus SN, Triadafilopoulos G. Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422 [Abstract] [Full Text] [Related]
6. Differences Between Patients with Heartburn Refractory to Vonoprazan and Those Refractory to Proton Pump Inhibitors. Matsumura T, Sonoda M, Okimoto K, Dao HV, Takahashi S, Akizue N, Horio R, Goto C, Kurosugi A, Kaneko T, Ohta Y, Taida T, Kikuchi A, Fujie M, Kato J, Kato N. Dig Dis Sci; 2024 Jun; 69(6):2132-2139. PubMed ID: 38622462 [Abstract] [Full Text] [Related]
7. The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors. Yamashita H, Kanamori A, Kano C, Hashimura H, Matsumoto K, Tsujimae M, Yoshizaki T, Momose K, Obata D, Eguchi T, Fujita M, Okada A. Digestion; 2017 Jun; 96(1):52-59. PubMed ID: 28662503 [Abstract] [Full Text] [Related]
8. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? de Bortoli N, Nacci A, Savarino E, Martinucci I, Bellini M, Fattori B, Ceccarelli L, Costa F, Mumolo MG, Ricchiuti A, Savarino V, Berrettini S, Marchi S. World J Gastroenterol; 2012 Aug 28; 18(32):4363-70. PubMed ID: 22969200 [Abstract] [Full Text] [Related]
11. Combined esophageal multichannel intraluminal impedance and pH monitoring (MII -pH) in the diagnostics and treatment of gastroesophageal reflux disease and its complications. Masiak W, Wallner G, Wallner J, Pedowski T, Solecki M. Pol Przegl Chir; 2011 Sep 28; 83(9):488-96. PubMed ID: 22166737 [Abstract] [Full Text] [Related]
12. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring. Kohata Y, Fujiwara Y, Machida H, Okazaki H, Yamagami H, Tanigawa T, Watanabe K, Watanabe T, Tominaga K, Arakawa T. J Gastroenterol Hepatol; 2012 Apr 28; 27 Suppl 3():58-62. PubMed ID: 22486873 [Abstract] [Full Text] [Related]
13. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease. Ranaldo N, Losurdo G, Iannone A, Principi M, Barone M, De Carne M, Ierardi E, Di Leo A. Cell Death Dis; 2017 Sep 07; 8(9):e3040. PubMed ID: 28880273 [Abstract] [Full Text] [Related]
14. Combined pH-impedance monitoring and high-resolution manometry of Japanese patients treated with proton-pump inhibitors for persistent symptoms of non-erosive reflux disease. Yamashita H, Ashida K, Fukuchi T, Nagatani Y, Koga H, Senda K, Eguchi T, Ubukata S, Kawaguchi S, Ueda A, Tanaka T, Ohashi R, Ito D. J Smooth Muscle Res; 2012 Sep 07; 48(5-6):125-35. PubMed ID: 23538509 [Abstract] [Full Text] [Related]
16. Persistent Postprandial Regurgitation vs Rumination in Patients With Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring. Nakagawa K, Sawada A, Hoshikawa Y, Nikaki K, Sonmez S, Woodland P, Yazaki E, Sifrim D. Am J Gastroenterol; 2019 Aug 07; 114(8):1248-1255. PubMed ID: 31246694 [Abstract] [Full Text] [Related]
17. Therapy of gastroesophageal reflux disease and functional dyspepsia overlaps with symptoms after usual-dose proton pump inhibitor: Acotiamide plus usual-dose proton pump inhibitor versus double-dose proton pump inhibitor. Takeuchi T, Takahashi Y, Kawaguchi S, Ota K, Harada S, Kojima Y, Sakamoto H, Kuramoto T, Kojima K, Sanomura M, Hoshimoto M, Higashino T, Itabashi T, Takada K, Sakaguchi M, Tominaga K, Kusano M, Higuchi K. J Gastroenterol Hepatol; 2018 Mar 07; 33(3):623-630. PubMed ID: 28865098 [Abstract] [Full Text] [Related]
19. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy. Kusano M, Hosaka H, Kawamura O, Kawada A, Kuribayashi S, Shimoyama Y, Yasuoka H, Mizuide M, Tomizawa T, Sagawa T, Sato K, Yamada M. J Gastroenterol; 2015 Mar 07; 50(3):298-304. PubMed ID: 24919745 [Abstract] [Full Text] [Related]